Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cefozopran Hydrochloride
2. 113981-44-5
3. Cefozopran (hydrochloride)
4. Cefozopran Hcl
5. 060i5c0grc
6. Cefozopran Monohydrochloride
7. Cefozopranhydrochloride
8. Unii-060i5c0grc
9. Sce-2787 Hydrochloride
10. Sce-2787.hcl
11. Schembl1229838
12. Schembl9286286
13. Hy-b0771a
14. (6r,7r)-7-[[(2z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrochloride
15. Mfcd00944908
16. Akos037648568
17. Ccg-270009
18. Cs-3504
19. Cefozopran Hydrochloride [mart.]
20. Cefozopran Hydrochloride [who-dd]
21. Bs-14644
22. A803043
23. (-)-1-(((6r,7r)-7-(2-(5-amino-1,2,4-thiadiazol-3-yl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1h-imidazo(1,2-b)pyridazin-4-ium Hydroxide Inner Salt, 7(sup 2)-(z)-(o-methyloxime), Hydrochloride
24. (6r,7r)-7-[[(2z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyimino-1-oxoethyl]amino]-3-(1-imidazo[1,2-b]pyridazin-4-iumylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Hydrochloride
25. (6r,7r)-7-[[(2z)-2-(5-azanyl-1,2,4-thiadiazol-3-yl)-2-methoxyimino-ethanoyl]amino]-3-(imidazo[1,2-b]pyridazin-4-ium-1-ylmethyl)-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Hydrochloride
26. Imidazo(1,2-b)pyridazinium, 1-((7-(((5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, Chloride, (6r-(6alpha,7beta(z)))-
Molecular Weight | 552.0 g/mol |
---|---|
Molecular Formula | C19H18ClN9O5S2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 6 |
Exact Mass | 551.0560847 g/mol |
Monoisotopic Mass | 551.0560847 g/mol |
Topological Polar Surface Area | 238 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 960 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
11
PharmaCompass offers a list of Cefozopran Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefozopran Hydrochloride manufacturer or Cefozopran Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefozopran Hydrochloride manufacturer or Cefozopran Hydrochloride supplier.
PharmaCompass also assists you with knowing the Cefozopran Hydrochloride API Price utilized in the formulation of products. Cefozopran Hydrochloride API Price is not always fixed or binding as the Cefozopran Hydrochloride Price is obtained through a variety of data sources. The Cefozopran Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 060I5C0GRC manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 060I5C0GRC, including repackagers and relabelers. The FDA regulates 060I5C0GRC manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 060I5C0GRC API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 060I5C0GRC supplier is an individual or a company that provides 060I5C0GRC active pharmaceutical ingredient (API) or 060I5C0GRC finished formulations upon request. The 060I5C0GRC suppliers may include 060I5C0GRC API manufacturers, exporters, distributors and traders.
click here to find a list of 060I5C0GRC suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 060I5C0GRC Drug Master File in Japan (060I5C0GRC JDMF) empowers 060I5C0GRC API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 060I5C0GRC JDMF during the approval evaluation for pharmaceutical products. At the time of 060I5C0GRC JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 060I5C0GRC suppliers with JDMF on PharmaCompass.
060I5C0GRC Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 060I5C0GRC GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 060I5C0GRC GMP manufacturer or 060I5C0GRC GMP API supplier for your needs.
A 060I5C0GRC CoA (Certificate of Analysis) is a formal document that attests to 060I5C0GRC's compliance with 060I5C0GRC specifications and serves as a tool for batch-level quality control.
060I5C0GRC CoA mostly includes findings from lab analyses of a specific batch. For each 060I5C0GRC CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
060I5C0GRC may be tested according to a variety of international standards, such as European Pharmacopoeia (060I5C0GRC EP), 060I5C0GRC JP (Japanese Pharmacopeia) and the US Pharmacopoeia (060I5C0GRC USP).